文献速递脑血管病

远程卒中能力与再灌注治疗及卒中结局

Reperfusion Treatment and Stroke Outcomes in Hospitals With Telestroke Capacity.
PubMed 文献 · JAMA Neurol · 2021-01-01

结果显示,远程卒中医院患者再灌注治疗率更高(6.8% vs 6.0%),30天死亡率更低(13.1% vs 13.6%),但在社区生活天数与费用上无差异。

要点

  • 远程卒中医院再灌注治疗率较对照医院高0.78个百分点(6.8% vs 6.0%)。
  • 远程卒中医院30天死亡率较对照医院低0.50个百分点(13.1% vs 13.6%)。
  • 再灌注治疗提升在低容量医院、农村居民及85岁以上患者中最明显。

核心结论

  • 在具备远程卒中能力的医院就诊的缺血性卒中患者更可能接受再灌注治疗,且30天死亡率更低。

研究设计与样本

  • 匹配基于社会人口学与临床特征、医院特征及入院月份和年份。

主要发现

  • 远程卒中医院再灌注治疗率为6.8%,对照医院为6.0%,差异0.78个百分点(95% CI 0.54-1.03,P < .001)。
  • 远程卒中医院30天死亡率为13.1%,对照医院为13.6%,差异0.50个百分点(95% CI 0.17-0.83,P = .003)。
  • 出院后社区生活天数与90天费用在两组间无差异。
  • 再灌注治疗增加在最低容量医院、农村居民及85岁及以上患者中最大。

临床怎么用

  • 对于无本地卒中专家的医院,远程卒中能力可能提高再灌注治疗可及性并改善短期生存。
  • 低容量医院、农村地区及高龄患者可能是远程卒中获益更明显的人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Telestroke is increasingly used in hospital emergency departments, but there has been limited research on its impact on treatment and outcomes. OBJECTIVE: To describe differences in care patterns and outcomes among patients with acute ischemic stroke who present to hospitals with and without telestroke capacity. DESIGN, SETTING, AND PARTICIPANTS: Patients with acute ischemic stroke who first presented to hospitals with telestroke capacity were matched with patients who presented to control hospitals without telestroke capacity. All traditional Medicare beneficiaries with a primary diagnosis of acute ischemic stroke (approximately 2.5 million) who presented to a hospital between January 2008 and June 2017 were considered. Matching was based on sociodemographic and clinical characteristics, hospital characteristics, and month and year of admission. Hospitals included short-term acute care and critical access hospitals in the US without local stroke expertise. In 643 hospitals with telestroke capacity, there were 76 636 patients with stroke who were matched 1:1 to patients at similar hospitals without telestroke capacity. Data were analyzed in July 2020. MAIN OUTCOMES AND MEASURES: Receipt of reperfusion treatment through thrombolysis with alteplase or thrombectomy, mortality at 30 days from admission, spending through 90 days from admission, and functional status as measured by days spent living in the community after discharge. RESULTS: In the final sample of 153 272 patients, 88 386 (57.7%) were female, and the mean (SD) age was 78.8 (10.4) years. Patients cared for at telestroke hospitals had higher rates of reperfusion treatment compared with those cared for at control hospitals (6.8% vs 6.0%; difference, 0.78 percentage points; 95% CI, 0.54-1.03; P < .001) and lower 30-day mortality (13.1% vs 13.6%; difference, 0.50 percentage points; 95% CI, 0.17-0.83, P = .003). There were no differences in days spent living in the community following discharge or in spending. Increases in reperfusion treatment were largest in the lowest-volume hospitals, among rural residents, and among patients 85 years and older. CONCLUSIONS AND RELEVANCE: Patients with ischemic stroke treated at hospitals with telestroke capacity were more likely to receive reperfusion treatment and have lower 30-day mortality.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Wilcock AD, Schwamm LH, Zubizarreta JR, et al. Reperfusion Treatment and Stroke Outcomes in Hospitals With Telestroke Capacity. JAMA Neurol. 2021. PMID: 33646272. doi:10.1001/jamaneurol.2021.0023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。